Results 121 to 130 of about 15,824 (192)

Within-host co-evolution of KPC variants: plasmid-mediated dissemination of <i>bla</i>_Kpc-194 and <i>bla</i>_Kpc-33 in ST11-KL64 hypervirulent <i>Klebsiella pneumoniae</i> driving ceftazidime-avibactam resistance. [PDF]

Microbiol Spectr
Ding L, Wu X, Xie Q, Liu L, Liang B, Shen S, Guo Y, Chen J, Hu F.   +8 more
europepmc   +1 more source

Current progress in antibacterial agents for carbapenem-resistant enterobacterales. [PDF]

Front Pharmacol
Xu W, Shang L, Li X, Yu J, Shen J, Li Y, He Q, Chen L, Wang D, Wei Y, Niu S.   +10 more
europepmc   +1 more source

Co-Administration Dosing of Ceftazidime-Avibactam and Aztreonam in Patients with Varying Renal Function for Carbapenem-Resistant Enterobacterales Infections via Monte Carlo Simulation. [PDF]

Infect Chemother
Hemapanpairoa J, Saelim W, Changpradub D, Santimaleeworagun W.   +3 more
europepmc   +1 more source

The <i>bla_KPC-249</i> -mediated mechanism drives the transition of ST463 <i>Pseudomonas aeruginosa</i> from Ceftazidime-Avibactam sensitivity to resistance during clinical treatment. [PDF]

Front Cell Infect Microbiol
Li X, Feng Y, Wu X, Shen H, Shang S, Tang W, Hu F, Liang H.   +7 more
europepmc   +1 more source

Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study. [PDF]

Open Forum Infect Dis
Cordova E, Balbuena JP, Mykietiuk A, Farina J, Gañete M, Scapellato P, Lespada MI, Nannini E, Contreras R, Cunto E, Barcelona L, Pasteran F, Salgueira C, Hojman M, Blanco M, Lopez Alegre H, Cox Fernandez WE, Ezcurra C, Godoy D, Biglia MA, Lopez Furst MJ, Mendez G, Aguirre Rios MF, Altclas J, Sanchez C, Stryjewski ME.   +25 more
europepmc   +1 more source

What every intensivist should know about the management of peritonitis in the intensive care unit [PDF]

, 2018
De Waele, Jan
core   +2 more sources

Suboptimal ceftazidime-avibactam exposure drives sequential <i>bla</i>_KPC mutations and intra-host coexistence of <i>Klebsiella pneumoniae</i> harboring distinct variants leading to persistent infection. [PDF]

Microbiol Spectr
Yang F, Yang W, Zhang J, Tang C, Ding L, Shen S, Zhou Y, Zhao H, Zhou J, Hu F.   +9 more
europepmc   +1 more source

High <i>in vitro</i> activity of aztreonam/avibactam against NDM-producing Enterobacterales with emerging resistance in <i>Escherichia coli</i> in the United States Mid-Atlantic region. [PDF]

Microbiol Spectr
Eklund E, Maruca T, Kruczynski K, Critchfield H, Murphy R, Keller E, Lee B, Patel A, Klein L, Torpey DA, Myers RA, Campodónico VL.   +11 more
europepmc   +1 more source

Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Karunanidhi A, Singh N, Watkins JV, Smith NM, Zang Y, Shan X, Espinoza G, Li J, Lang Y, Bulitta JB, Bulman ZP.   +10 more
europepmc   +1 more source

KPC-33 and ompK37 mutations: Unraveling the mechanism of ceftazidime/avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae. [PDF]

PLoS One
Zhao S, Ye L, Song S, Sun J, Xu J, Jiang F, Kang H.   +6 more
europepmc   +1 more source